v3.25.4

Business (Tables) | 6 Months Ended
--- | ---
Dec. 31, 2025
Schedule Of Entities In Control [Abstract] |
Summary of entities in control | The consolidated financial statements of Benitec Biopharma Inc. are presented in United States dollars and consist of Benitec Biopharma Inc. and its wholly owned subsidiaries as listed below. Aside from Benitec Biopharma Proprietary Limited, the international subsidiaries are dormant.
|  | Principal place of business/country of incorporation
Benitec Biopharma Proprietary Limited (“BBL”) |  | Australia
Benitec Australia Proprietary Limited |  | Australia
Benitec Limited |  | United Kingdom
Benitec, Inc. |  | USA
Benitec LLC |  | USA
RNAi Therapeutics, Inc. |  | USA
Tacere Therapeutics, Inc. |  | USA
Benitec IP Holdings, Inc. |  | USA

X
- References No definition available. + Details
Name: | bntc_ScheduleOfEntitiesInControlAbstract
Namespace Prefix: | bntc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of entities in control. + References No definition available. + Details
Name: | bntc_ScheduleOfEntitiesInControlTableTextBlock
Namespace Prefix: | bntc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration